$KIMS : Temporary Margin Pressures Belie Strong Growth Outlook

$KIMS is rapidly growing its footprint, having expanded its bed capacity by 25% year-on-year to 6,464 beds in FY26. The company has another 1,300 beds in the pipeline, featuring major upcoming projects in Telangana (Kondapur II), Kerala (Palakkad), and an asset-light super-specialty facility in Chennai. Near-Term Margin Headwinds: While FY26 revenue surged by 29% year-on-year, aggressive operational scaling temporarily compressed EBITDA margins from 25.8% to 20.5%. This expected compression is tied to initial gestation costs and insurance empanelment delays at newly commissioned hospitals, whereas mature facilities maintain healthy margins of 28–29%. Promising New Facility Trajectories: Newly launched units are scaling efficiently; the Thane facility achieved EBITDA neutrality by the end of March, the Bengaluru-Mahadevapura hospital is pacing ahead of schedule to break even by October 2026, and the Bengaluru Electronic City unit is projected to break even by late FY27. Robust Operational Volume Growth: Operational fundamentals remain robust, characterized by industry-leading growth in patient traffic—inpatient volumes climbed 16% and outpatient volumes rose 25% in FY26. Furthermore, a richer case mix pushed the Average Revenue Per Operating Bed (ARPOB) up by 14% to Rs 44,644. Operating Leverage & Balance Sheet Strength: Current occupancy sits around 50% due to the rapid addition of new beds, leaving substantial room for profitability to surge as utilization climbs. Additionally, a proposed Rs 1,500-crore Qualified Institutional Placement (QIP) will strengthen the balance sheet by paying down debt and funding future growth.